Skip to main content
SpringerLink
Log in

18-gene assay may be cost effective in colorectal cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Issa AM, et al. A pharmacoeconomic decision analytic model of multigene molecular diagnostics for colorectal cancer precision medicine. 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management : abstr. 836, 22 Aug 2018. Available from: URL: https://www.pharmacoepi.org/meetings/34icpe/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

18-gene assay may be cost effective in colorectal cancer. PharmacoEcon Outcomes News 813, 3 (2018). https://doi.org/10.1007/s40274-018-5310-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5310-7

Search

Navigation